Q&A
The challenges of pediatric clinical trials
Pediatric trials are complicated – but what unique challenges do they pose?
Q&A
Pediatric trials are complicated – but what unique challenges do they pose?
Agilent Technologies has announced plans for a nucleic acid API manufacturing plant in Colorado.
Ashfield, a provider of outsourced healthcare services to pharmaceutical, device, and biotech companies, has announced a new international initiative, Ashfield Cares.
The US FDA has criticised Chinese manufacturer Concept Products for not fixing cGMP violations observed by inspectors who visited its manufacturing site in Tianjin.
PharmaTech LLC has recalled more drugs made at the Florida plant that was linked an outbreak of B. cepacia last month.
Pharmaceutical Product Development (PPD) is set to acquire evidence-based solutions provider Evidera, as the need for real-world data continues to grow.
Catalent and Zumutor Biologics have combined their technologies to create antibodies with enhanced Antibody Dependent Cellular Cytotoxicity (ADCC) without compromising production levels.
Pfizer unit Hospira has recalled one lot of the anaesthetic made at its facility in Rocky Mount, North Carolina after particulate matter was found in a vial of the drug.